Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Catecholamines Market

Catecholamines Market Share

Report ID: GMI6580
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Catecholamines Market Share

Major market players operating in the catecholamines market include

Viatris, Inc.
Novartis International AG
Amneal Pharmaceuticals
Teva Pharmaceutical Industries Ltd
Baxter International
Breckenridge Pharmaceutical, Inc.

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Catecholamines industry size crossed USD 3.9 billion in 2022 and is estimated to reach USD 7.6 billion by end of 2032 due to the surge in technological advancements in drug delivery systems.

The epinephrine type segment held 49.4% of the catecholamines industry share in 2022 and is projected to witness significant growth through 2032 driven by the rising prevalence of allergies and increased awareness of anaphylactic reactions worldwide.

The hospital pharmacy distribution channel segment recorded 49.8% of the catecholamines industry share in 2022 due to the surging need for ensuring the timely availability, accurate preparation, and proper administration of critical medications.

North America held 40.8% share of the catecholamines industry in 2022 and is anticipated to witness considerable growth rate through 2032 owing to presence of advanced healthcare infrastructure and higher emphasis on emergency medical care.